The Justice Department announced today that Assertio Therapeutics Inc., formerly known as Depomed Inc., (Assertio), a pharmaceutical company headquartered in Lake Forest, Illinois, has agreed to pay $3.6 million to resolve claims that Assertio violated the False Claims Act (FCA) by causing the submission of false claims for the transmucosal immediate-release fentanyl (TIRF) Read More
Home » Pharmaceutical Manufacturer Assertio Therapeutics Inc. Agrees to Pay
Pharmaceutical Manufacturer Assertio Therapeutics Inc. Agrees to Pay
Related Posts
California Man Pleads Guilty in Connection with $16M Hospice Fraud
A California man pleaded guilty today in connection with his role in defrauding Medicare of nearly $16 million through sham hospice companies and laundering the… BronCalifornia Man Pleads Guilty in Connection with $16M Hospice Fraud
Environmental Crimes Bulletin
This month’s Bulletin includes cases involving emissions tampering, animal fighting, wastewater discharges, refrigerant smuggling, wildlife trafficking, and more. Read More
Defense Contractor Berg Co. Agrees to Pay $3.3M to Resolve Allegations
Berg Companies Inc. (Berg) has agreed to pay $3.3 million to resolve allegations that it violated the False Claims Act by submitting, or causing the… BronDefense Contractor Berg Co. Agrees to Pay $3.3M to Resolve Allegations